Cytogen Inc (217330) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.059x

Based on the latest financial reports, Cytogen Inc (217330) has a cash flow conversion efficiency ratio of -0.059x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.13 Billion ≈ $-1.44 Million USD) by net assets (₩35.99 Billion ≈ $24.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Cytogen Inc for the company's overall valuation and market capitalisation.

Cytogen Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Cytogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cytogen Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cytogen Inc ranked by their cash flow conversion efficiency. See how well can Cytogen Inc service its debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Toba Pulp Lestari Tbk JK:INRU	-0.187x
TOPMATERIAL LTD KQ:360070	0.013x
Turism Felix B RO:TUFE	0.094x
Royalindo Investa Wijaya JK:INDO	0.007x
SMCore.Inc KQ:007820	-0.082x
Carnival Industrial Corp TW:1417	0.035x
Nh Prime Reit Co Ltd KO:338100	N/A
MINDs Lab Inc. KQ:377480	-0.082x

Annual Cash Flow Conversion Efficiency for Cytogen Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Cytogen Inc from 2014 to 2025. View today's stock price for Cytogen Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩35.99 Billion ≈ $24.39 Million	₩-6.95 Billion ≈ $-4.71 Million	-0.193x	+1.50%
2024-12-31	₩48.58 Billion ≈ $32.92 Million	₩-9.53 Billion ≈ $-6.46 Million	-0.196x	-37.81%
2023-12-31	₩53.36 Billion ≈ $36.16 Million	₩-7.59 Billion ≈ $-5.15 Million	-0.142x	+87.38%
2022-12-31	₩5.66 Billion ≈ $3.83 Million	₩-6.38 Billion ≈ $-4.32 Million	-1.128x	-396.17%
2021-12-31	₩23.01 Billion ≈ $15.59 Million	₩-5.23 Billion ≈ $-3.54 Million	-0.227x	+6.68%
2020-12-31	₩18.34 Billion ≈ $12.43 Million	₩-4.47 Billion ≈ $-3.03 Million	-0.244x	-29.58%
2019-12-31	₩17.92 Billion ≈ $12.14 Million	₩-3.37 Billion ≈ $-2.28 Million	-0.188x	-49.56%
2018-12-31	₩22.04 Billion ≈ $14.94 Million	₩-2.77 Billion ≈ $-1.88 Million	-0.126x	+72.70%
2017-12-31	₩4.73 Billion ≈ $3.21 Million	₩-2.18 Billion ≈ $-1.48 Million	-0.460x	+90.73%
2016-12-31	₩475.51 Million ≈ $322.25K	₩-2.36 Billion ≈ $-1.60 Million	-4.969x	-551.88%
2015-12-31	₩2.66 Billion ≈ $1.80 Million	₩-2.03 Billion ≈ $-1.37 Million	-0.762x	+64.00%
2014-12-31	₩484.59 Million ≈ $328.40K	₩-1.03 Billion ≈ $-695.41K	-2.118x	--

About Cytogen Inc

KQ:217330 Korea Diagnostics & Research

Market Cap

$48.00 Million

₩70.82 Billion KRW

Market Cap Rank

#22149 Global

#1380 in Korea

Share Price

₩3070.00

Change (1 day)

+0.33%

52-Week Range

₩2320.00 - ₩9420.00

All Time High

₩22599.98